arrow
Back
S

Sara A. Hurvitz

Yonsei University Health System

76H-index
712Paper Count
3.1WCitation Count
Published Papers 260
Publication Date
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies
err2026-01-01
err0
PREAI
errPark, Yeon Hee; Cortes, Javier; Modi, Shanu; Hurvitz, Sara A.; Bianchini, Giampaolo; Iwata, Hiroji; Shitara, Kohei; Siena, Salvatore; Goto, Yasushi; Ku, Geoffrey Y.; Powell, Charles A.; Swain, Sandra M.; Arunachalam, Meena; Janek, Martin; Cheng, Yingkai; Chu, Changan; Verma, Purnima; Kuptsova-Clarkson, Nataliya; Mathias, Elton; Goodman, Erin; Rugo, Hope S.
errShare
errSave
Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03
err2025-11-18
err0
PREAI
errC. Saura; J. Cortés; S. Modi; S.-B. Kim; E. Hamilton; S.A. Hurvitz; I.E. Krop; G. Curigliano; H. Iwata; S.-A. Im; P. Herbolsheimer; M. Karnoub; A. Boran; Y. Kuwahara; A. Egorov; F. André
errShare
errSave
Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival☆
err2025-10-17
err0
errOAAI
errJ. Crown; D. Stroyakovskii; D.A. Yardley; C.-S. Huang; P.A. Fasching; A. Bardia; S. Chia; S.-A. Im; M. Martin; B. Xu; C.H. Barrios; M. Untch; R. Moroose; S.A. Hurvitz; G.N. Hortobagyi; D.J. Slamon; F. Visco; G. Spera; J.P. Zarate; D. Halligan; Z. Li; S. Loi
errShare
errSave
Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers
err2025-10-17
err0
errOAAI
errSara Hurvitz; Matteo Simonelli; Ramón Yarza; David Berz; Shigehisa Kitano; Gianluca Del Conte; Daniel Acosta Eyzaguirre; Bernard Gaston Doger de Speville Uribe; Daniela Maier; Damijan Erzen; Sila Aykut Yazgili; Giuseppe Curigliano; Ting Deng; Min Yan; Qingyuan Zhang; Xian Wang; Izuma Nakayama; Kohei Shitara
errShare
errSave
Inflammation and dimensions of fatigue in women with early stage breast cancer: A longitudinal examination
errCANCER
IF5.1
err2025-10-15
err0
errOAAI
errBower, Julienne E.; Radin, Arielle; Ganz, Patricia A.; Irwin, Michael R.; Cole, Steve W.; Petersen, Laura; Asher, Arash; Hurvitz, Sara A.; Crespi, Catherine M.
errShare
errSave
Corrigendum to “Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3”
err2025-10-15
err0
errOAAI
errM.P. Goetz; M. Toi; J. Huober; J. Sohn; O. Trédan; I.H. Park; M. Campone; S.-C. Chen; L.M. Manso; S. Paluch-Shimon; O.C. Freedman; J. O’Shaughnessy; X. Pivot; S.M. Tolaney; S.A. Hurvitz; A. Llombart-Cussac; V. André; A. Saha; G. van Hal; A. Shahir; H. Iwata; S.R.D. Johnston
errShare
errSave
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
err2025-10-01
err4
PREAI
errCortes, Javier; Punie, Kevin; Barrios, Carlos; Hurvitz, Sara A.; Schneeweiss, Andreas; Sohn, Joohyuk; Tokunaga, Eriko; Brufsky, Adam; Park, Yeon Hee; Xu, Binghe; Hegg, Roberto; Oliveira, Mafalda; Fabi, Alessandra; Vaksman, Natalya; Valdez, Theresa; Zhang, Xinrui; Lai, Catherine; Tolaney, Sara M.
errShare
errSave
The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study
err2025-06-01
err0
errOAAI
errL. García-Estévez; A. Bardia; H.S. Rugo; L.A. Carey; V.C. Diéras; S. Loibl; M. Piccart; L. Gianni; K. Kalinsky; J. O’Shaughnessy; S.A. Hurvitz; E. Harting; T. Valdez; S. Phan; C. Lai; J. Cortés
errShare
errSave
Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study
err2025-05-05
err0
PREAI
errSantiago Escrivá-de-Romani; Juan M Cejalvo; Emilio Alba; Jennifer Friedmann; Álvaro Rodríguez-Lescure; Marie-France Savard; Rossanna C Pezo; Maria Gion; Manuel Ruiz-Borrego; Erika Hamilton; Timothy Pluard; Marc Webster; Muralidhar Beeram; Hannah Linden; Cristina Saura; Diana Shpektor; Bob Salim; Phoebe Harvey; Sara A Hurvitz
errShare
errSave
Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists
err2025-05-03
err0
errOAAI
errHope S. Rugo; Aditya Bardia; William J. Gradishar; Erika P. Hamilton; Sara A. Hurvitz; Komal Jhaveri; Reshma Mahtani; Sara M. Tolaney
errShare
errSave
Unmet need for previously untreated metastatic triple-negative breast cancer: a real-world study of patients diagnosed from 2011 to 2022 in the United States
err2025-03-31
err0
errOAAI
errPunie, Kevin; Kurian, Allison W.; Ntalla, Ioanna; Sjekloca, Nikoleta; Estrin, Adina; Dabrowski, Elizabeth C.; Lai, Catherine; Hurvitz, Sara
errShare
errSave
Interim analysis (IA) of the giredestrant (G) plus samuraciclib (SAMURA) arm in MORPHEUS breast cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with oestrogen receptor-positive (ER+), HER2-negative, locally advanced/metastatic BC (LA/mBC)
err2024-09-01
err0
PREAI
errOliveira, M.; Gion Cortes, M.; Jung, K. H.; Bermejo, B.; Hurvitz, S. A.; Sadeghi, S.; Wander, S.; Im, S-A.; Gal-Yam, E.; Zhu, J.; Schwab, R.; Ngo, H.; Collier, A.; Cannon, M.; Cahuzac, C.; Moreno, P. D. Perez; Mcintosh, S.; Saavedra Serrano, C.; Sonnenblick, A.
errShare
errSave
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HRD, HER2L advanced breast cancer: final overall survival results of MONARCH 3
err2024-08-01
err17
errOAAI
errGoetz, M. P.; Toi, M.; Huober, J.; Sohn, J.; Tredan, O.; Park, I. H.; Campone, M.; Chen, S. -C.; Manso, L. M.; Paluch-Shimon, S.; Freedman, O. C.; O'Shaughnessy, J.; Pivot, X.; Tolaney, S. M.; Hurvitz, S. A.; Llombart-Cussac, A.; Andre, V.; Saha, A.; van Hal, G.; Shahir, A.; Iwata, H.; Johnston, S. R. D.
errShare
errSave
VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+/HER2-advanced breast cancer
err2024-07-29
err8
errOAAI
errHamilton, Erika P.; Ma, Cynthia; De Laurentiis, Michelino; Iwata, Hiroji; Hurvitz, Sara A.; Wander, Seth A.; Danso, Michael; Lu, Dongrui R.; Smith, Julia Perkins; Liu, Yuan; Tran, Lana; Anderson, Sibyl; Campone, Mario
errShare
errSave
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer (vol 10, 33, 2024)
err2024-07-09
err1
errOAAI
errHurvitz, Sara A.; Bardia, Aditya; Punie, Kevin; Kalinsky, Kevin; Carey, Lisa A.; Rugo, Hope S.; Dieras, Veronique; Phan, See; Delaney, Rosemary; Zhu, Yanni; Tolaney, Sara M.
errShare
errSave
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer (vol 8, 98, 2022)
err2024-06-06
err0
errOAAI
errRugo, Hope S.; Tolaney, Sara M.; Loirat, Delphine; Punie, Kevin; Bardia, Aditya; Hurvitz, Sara A.; O'Shaughnessy, Joyce; Cortes, Javier; Dieras, Veronique; Carey, Lisa A.; Gianni, Luca; Piccart, Martine J.; Loibl, Sibylle; Goldenberg, David M.; Hong, Quan; Olivo, Martin; Itri, Loretta M.; Kalinsky, Kevin
errShare
errSave
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial
err2024-06-02
err6
errOAAI
errCortes, Javier; Hurvitz, Sara A.; Im, Seock-Ah; Iwata, Hiroji; Curigliano, Giuseppe; Kim, Sung-Bae; Chiu, Joanne W. Y.; Pedrini, Jose L.; Li, Wei; Yonemori, Kan; Bianchini, Giampaolo; Loi, Sherene; Borges, Giuliano S.; Wang, Xian; Bachelot, Thomas; Nakatani, Shunsuke; Ashfaque, Shahid; Liang, Zhengkang; Egorov, Anton; Hamilton, Erika
errShare
errSave
VERITAC-3: A randomized phase 3 study, with a lead-in, of first-line vepdegestrant plus palbociclib vs letrozole plus palbociclib in estrogen receptorpositive/human epidermal growth factor receptor 2-negative advanced breast cancer
err2024-05-02
err0
PREAI
errWander, Seth; Hamilton, Erika; Campone, Mario; Danso, Michael; Hurvitz, Sara; Iwata, Hiroji; Chappey, Colombe; Yang, Derek; Smith, Julia Perkins; Liu, Yuan; Zhang, Yuanyuan; Anderson, Sibyl; de Laurentiis, Michelino
errShare
errSave